Authors:
Tsavaris, N
Kosmas, C
Vadiaka, M
Kontos, A
Katsorida, M
Dimitrakopoulos, A
Zerai, A
Koufos, C
Citation: N. Tsavaris et al., Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study, J EXP CL C, 20(1), 2001, pp. 29-34
Authors:
Tsavaris, N
Skarlos, D
Bacoyiannis, C
Aravantinos, G
Kosmas, C
Retalis, G
Panopoulos, C
Vadiaka, M
Dimitrakopoulos, A
Kostantinidis, K
Mitropoulos, D
Bougas, D
Pantazopoulos, D
Kosmidis, P
Citation: N. Tsavaris et al., Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma, J INTERF CY, 20(8), 2000, pp. 685-690
Authors:
Dimitrakopoulos, A
Takou, A
Haida, A
Molangeli, S
Gialeraki, A
Kordossis, T
Citation: A. Dimitrakopoulos et al., The prevalence of hepatitis B and C in HIV-positive Greek patients: Relationship to survival of deceased AIDS patients, J INFECTION, 40(2), 2000, pp. 127-131
Authors:
Tsavaris, NB
Koufos, C
Katsikas, M
Dimitrakopoulos, A
Athanasiou, E
Linardaki, G
Citation: Nb. Tsavaris et al., Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy, J PAIN SYMP, 18(3), 1999, pp. 218-222